Bibliography: Emerging Therapies in Psychiatry

Canuso CMSJ, Singh JB, Fedgchin M, et al.: Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry (Epub ahead of print, April 16, 2018)Google Scholar

Freedman R, Brown AS, Cannon TD, et al.: Can a framework be established for the safe use of ketamine? Am J Psychiatry (Epub ahead of print, April 16, 2018)Google Scholar

Grunebaum MF, Galfalvy HC, Choo TH, et al.: Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry 2018; 175:327–335Crossref, Google Scholar

Khalsa SS, Adolphs R, Cameron OG, et al.: Interoception and mental health: a roadmap. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging doi: 10.1016/j.bpsc.2017.12.004Google Scholar

McClintock SM, Reti IM, Carpenter LL, et al.: Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (RTMS) in the treatment of depression. J Clin Psychiatry 2018; 79:16cs10905Crossref, Google Scholar

Widge AS, Malone DA Jr, Dougherty DD: Closing the loop on deep brain stimulation for treatment-resistant depression. Front Neurosci 2018; 12:175Google Scholar

Wilkinson ST, Ballard ED, Bloch MH, et al.: The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry 2018; 175:150–158Crossref, Google Scholar

Zanos P, Thompson SM, Duman RS, et al.: Convergent mechanisms underlying rapid antidepressant action. CNS Drugs 2018; 32:197–227Crossref, Google Scholar

Alyami M, Giri B, Alyami H, et al.: Social anxiety apps: a systematic review and assessment of app descriptors across mobile store platforms. Evid Based Ment Health 2017; 20:65–70Crossref, Google Scholar

Chan S, Godwin H, Gonzalez A, et al.: Review of use and integration of mobile apps into psychiatric treatments. Curr Psychiatry Rep 2017; 19:96Crossref, Google Scholar

Firth J, Torous J, Nicholas J, et al.: Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. J Affect Disord 2017; 218:15–22Crossref, Google Scholar

Firth J, Torous J, Nicholas J, et al.: The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry 2017; 16:287–298Crossref, Google Scholar

Fortney JC, Unützer J, Wrenn G, et al: A tipping point for measurement-based care. Psychiatr Serv 2017; 68:179–188Google Scholar

Garay RP, Zarate CA Jr, Charpeaud T, et al.: Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Rev Neurother 2017; 17:593–609Crossref, Google Scholar

Hilty DM, Chan S, Hwang T, et al: Advances in mobile mental health: opportunities and implications for the spectrum of e-mental health services. mHealth 2017; 3:34Google Scholar

Hung SY, Fu WM: Drug candidates in clinical trials for Alzheimer’s disease. J Biomed Sci 2017; 24:47 [Review]Crossref, Google Scholar

Insel TR: Digital phenotyping: technology for a new science of behavior. JAMA 2017; 318:1215–1216Crossref, Google Scholar

Krystal JH, Abdallah CG, Averill LA, et al.: Synaptic loss and the pathophysiology of PTSD: implications for ketamine as a prototype novel therapeutic. Curr Psychiatry Rep 2017; 19:74Crossref, Google Scholar

Luik AI, Kyle SD, Espie CA: Digital cognitive behavioral therapy (dCBT) for insomnia: a state-of-the-science review. Curr Sleep Med Rep 2017; 3:48–56Crossref, Google Scholar

Maples-Keller JL, Bunnell BE, Kim SJ, et al.: The use of reality technology in the treatment of anxiety and other psychiatric disorders. Harvard Review of Psychiatry 2015; 25(3):103–113Crossref, Google Scholar

Naumann J, Grebe J, Kaifel S, et al.: Effects of hyperthermic baths on depression, sleep and heart rate variability in patients with depressive disorder: a randomized clinical pilot trial. BMC Complement Altern Med 2017; 17:172Crossref, Google Scholar

Rizzo AS, Koenig ST: Is clinical virtual reality ready for primetime? Neuropsychology 2017; 31:877–899Crossref, Google Scholar

Wilkinson ST, Wright D, Fasula MK, et al.: Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression. Psychother Psychosom 2017; 86:162–167Crossref, Google Scholar

Armontrout J, Torous J, Fisher M, et al.: Mobile mental health: navigating new rules and regulations for digital tools. Curr Psychiatry Rep 2016; 18:91, 016–0726, xCrossref, Google Scholar

Duman RS, Aghajanian GK, Sanacora G, et al.: Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 2016; 22:238–249Crossref, Google Scholar

Fawcett J, Rush AJ, Vukelich J, et al.: Clinical experience with high-dosage pramipexole in patients with treatment-resistant depressive episodes in unipolar and bipolar depression. Am J Psychiatry 2016; 173:107–111Crossref, Google Scholar

Garay RP, Citrome L, Grossberg GT, et al.: Investigational drugs for treating agitation in persons with dementia. Expert Opin Investig Drugs 2016; 25:973–983Crossref, Google Scholar

Inagaki TK, Irwin MR, Moieni M, et al.: A Pilot study examining physical and social warmth: higher (non-febrile) oral temperature is associated with greater feelings of social connection. PLoS One 2016; 11:e0156873Crossref, Google Scholar

Possemato K, Kuhn E, Johnson E, et al.: Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. Gen Hosp Psychiatry 2016; 38:94–98Crossref, Google Scholar

Ranallo PA, Kilbourne AM, Whatley AS, et al.: Behavioral health information technology: from chaos to clarity. Health Aff (Millwood) 2016; 35:1106–1113Crossref, Google Scholar

Redlich R, Opel N, Grotegerd D, et al.: Prediction of individual response to electroconvulsive therapy via machine learning on structural magnetic resonance imaging data. JAMA Psychiatry 2016; 73:557–564Crossref, Google Scholar

Sarris J, Murphy J, Mischoulon D, et al: Adjunctive nutraceuticals for depression: a systematic review and meta-analyses. Am J Psychiatry 2016; 173:575–587Google Scholar

Singh JB, Fedgchin M, Daly E, et al.: Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study. Biol Psychiatry 2016; 80:424–431Crossref, Google Scholar

Berlim MT, van den Eynde F, Tovar-Perdomo S, et al.: Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 2014; 44:225–239Crossref, Google Scholar

Firth J, Torous J: Smartphone apps for schizophrenia: a systematic review. JMIR Mhealth Uhealth 2015; 3:e102Crossref, Google Scholar

Jain SH, Powers BW, Hawkins JB, et al.: The digital phenotype. Nat Biotechnol 2015; 33:462–463Crossref, Google Scholar

Nicholas J, Larsen ME, Proudfoot J, et al.: Mobile apps for bipolar disorder: a systematic review of features and content quality. J Med Internet Res 2015; 17:e198Crossref, Google Scholar

Raison CL, Hale MW, Williams LE, et al.: Somatic influences on subjective well-being and affective disorders: the convergence of thermosensory and central serotonergic systems. Front Psychol 2015; 5:1580Crossref, Google Scholar